[Use of corticosteroids after esophageal dilations on patients with corrosive stenosis: prospective, randomized and double-blind study]

Rev Assoc Med Bras (1992). 2003 Jul-Sep;49(3):286-92. doi: 10.1590/s0104-42302003000300033. Epub 2003 Nov 5.
[Article in Portuguese]

Abstract

Objective: To determine triancinolone intralesional injections effects in association with esophageal dilations in corrosive stenosis cases, by means of a double-blind and randomized study.

Method: Fourteen adults patients (6 men and 8 women) with severe esophageal corrosive stenosis were randomized in two groups: Group A: treated by esophageal dilations and posterior triancinolone 10 mg/ml intralesional injection; Group B: treated by esophageal injections and posterior saline solution 0,9% injection (placebo). New applications were made based on the patient symptomatology. It had been analysed dilation frequency, obtained diameters and dysphagia before and after the research, for 12 months.

Results: Eleven patients had ingested sodium hydroxide, two had ingested ammoniac and one had taken muriatic acid. There was no statistic difference (p > 0.05) in dilation frequency and dysphagia between the groups. However, an improvement in obtained diameter was observed in the corticosteroids group in comparison with control group (p < 0.05). By comparing groups before and after steroids, the final results were very favorable in group A CONCLUSION: Multiple intralesional injections of triancinolone hexacetonide 10 mg/ml in association with esophageal dilations increase obtained diameters in succeeding sessions.

Publication types

  • Clinical Trial
  • English Abstract
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / administration & dosage*
  • Burns, Chemical / complications*
  • Combined Modality Therapy
  • Dilatation* / methods
  • Double-Blind Method
  • Esophageal Stenosis / chemically induced
  • Esophageal Stenosis / drug therapy*
  • Esophagoscopy
  • Female
  • Follow-Up Studies
  • Humans
  • Injections, Intralesional
  • Male
  • Middle Aged
  • Prospective Studies
  • Severity of Illness Index
  • Treatment Outcome
  • Triamcinolone Acetonide / administration & dosage*
  • Triamcinolone Acetonide / analogs & derivatives*

Substances

  • Anti-Inflammatory Agents
  • Triamcinolone Acetonide
  • triamcinolone hexacetonide